Topiramate for essential tremor. (Q38836991)

PubMed publication ID

6 September 2017

0 references

Topiramate for essential tremor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Roberta Allegra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Graziella Filippini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Alessandra Nicoletti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Graziella Quattrocchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Carlo Colosimo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

Mario Zappia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

publication date

14 April 2017

1 reference

PubMed publication ID

28409827

Cochrane Database of Systematic Reviews

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

page(s)

CD009683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Topiramate in essential tremor: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Low doses of topiramate are effective in essential tremor: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Combined topiramate and declorazepam therapy in a patient affected by essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Is essential tremor benign?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Task force report: scales for screening and evaluating tremor: critique and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Prevalence of essential tremor. Results from the Copiah County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Efficacy of alprazolam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Essential tremor: a heterogenous disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Disability in essential tremor: effect of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Diagnostic criteria for essential tremor: a population perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Clinical practice. Essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

A teaching videotape for the assessment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Double-blind controlled trial of gabapentin in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Essential tremor: differential diagnosis and current therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Essential tremor in Rochester, Minnesota: a 45-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Prevalence of essential tremor: a door-to-door survey in Terrasini, Sicily. Sicilian Neuro-Epidemiologic Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Understanding controlled trials. Crossover trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Molecular pharmacology of topiramate: managing seizures and preventing migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Management of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009683.PUB2

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action

21 January 2018

1 reference

12 December 2020

Topiramate and essential tremor

1 reference

12 December 2020

Introduction. Essential tremor

1 reference

12 December 2020

Criteria for the diagnosis of essential tremor

1 reference

12 December 2020

Tremor assessment and quality of life measurements

1 reference

12 December 2020

Mechanism of action of newer anticonvulsants.

1 reference

12 December 2020

Essential tremor. Epidemiology, diagnosis, and treatment

1 reference

12 December 2020

1 reference

12 December 2020

Topiramate in refractory essential tremor

1 reference

12 December 2020

Low-dose topiramate (topamax) in the treatment of essential tremor

1 reference

12 December 2020

Acute and chronic effects of propranolol and primidone in essential tremor

1 reference

12 December 2020

A community survey of Parkinson's disease.

1 reference

12 December 2020

A double-blind trial of clonazepam in benign essential tremor

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor

1 reference

12 December 2020

Agreement among movement disorder specialists on the clinical diagnosis of essential tremor

1 reference

12 December 2020

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

1 reference

12 December 2020

Clinical measurement of tremor.

1 reference

12 December 2020

Pharmacologic treatment of tremor

1 reference

12 December 2020

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

1 reference

12 December 2020

10.1002/14651858.CD009683.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json

14 May 2020

PubMed publication ID

28409827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6478240&resulttype=core&format=json